Home­grown mR­NA Thai vac­cine for Covid-19 could be ready by year end — re­port

The Thai Food and Drug Ad­min­is­tra­tion will soon re­view tri­al re­sults from its coun­try’s first lo­cal­ly-de­vel­oped Covid-19 vac­cine, which us­es the same mR­NA tech­nol­o­gy that suc­cess­ful vac­cines from Pfiz­er/BioN­Tech and Mod­er­na have al­so em­ployed. If all goes well, Thai­land will roll out its first home­grown vac­cine by the end of this year, its gov­ern­ment has said.

The first lot of the vac­cine was pro­duced by BioNet-Asia, and de­vel­oped by Chu­la­longko­rn Uni­ver­si­ty re­searchers, the Bangkok Post re­port­ed. The jab, dubbed Chu­la­Cov19, has yet to be­gin clin­i­cal tri­als in hu­mans but ex­pects to lat­er this year, the Chu­la Vac­cine Re­search Cen­ter said. The cen­ter worked in col­lab­o­ra­tion with UPenn Pro­fes­sor Drew Weiss­man, who al­so worked on the mR­NA vac­cine tech that Pfiz­er/BioN­Tech de­ployed.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER